XML 69 R48.htm IDEA: XBRL DOCUMENT v3.22.4
Earnings per Share (Tables)
12 Months Ended
Dec. 31, 2022
Earnings Per Share [Abstract]  
Schedule of Weighted Average Number of Shares

 

 

For the Years Ended December 31,

 

 

 

2022

 

 

2021

 

 

2020

 

Weighted average common shares outstanding - basic

 

 

46,334

 

 

 

46,009

 

 

 

44,477

 

Effect of dilutive securities:

 

 

 

 

 

 

 

 

 

Restricted shares

 

 

71

 

 

 

139

 

 

 

 

Performance shares

 

 

408

 

 

 

542

 

 

 

 

Weighted average common shares outstanding - assuming dilution

 

 

46,813

 

 

 

46,690

 

 

 

44,477

 

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

For the year ended December 31, 2020, the number of outstanding performance shares and restricted shares of Core Laboratories N.V. common stock that were excluded from diluted earnings per share calculation, as their impact would be antidilutive, were as follows (in thousands):

 

 

December 31, 2020

 

Performance shares

 

 

308

 

Restricted shares

 

 

189